GP-Act III Acquisition Corp. (GPATW) Stock Analysis
GP-Act III Acquisition Corp.
$0.18
+$0.00 (+0.00%)
Last Updated: May 26, 2026
Price History
No price data available
Analysis
Company Overview
GP-Act III Acquisition Corp., operating under the ticker GPATW, is a special purpose acquisition company structured to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II before changing its name to GP-Act III Acquisition Corp., indicating a progression in its lifecycle as a SPAC seeking a target. While the specific sector and industry classifications are currently listed as N/A, the entity functions within the broader financial market as an intermediary vehicle designed to facilitate corporate consolidation rather than operating a traditional product-based industry. The company's scale is defined by a market cap and annual revenue that are listed as N/A, alongside an employee count also recorded as N/A, which suggests the entity operates with a minimal operational footprint typical of SPACs prior to completing a business combination. The absence of defined market capitalization and revenue figures in the available data indicates that the company has not yet generated significant operating income or established a large market position independent of its capital structure, positioning it as a vehicle awaiting a transaction to define its commercial scope and economic magnitude.
Financial Health
The financial performance of GP-Act III Acquisition Corp. is characterized by a net income of $12.30M over the trailing twelve months, while revenue, EBITDA, and operating margins are reported as N/A or 0.0%, creating a distinct gap where profitability exists despite a lack of traditional revenue streams or operating income. This divergence between a positive net income of $12.30M and the 0.0% gross, operating, and profit margins reveals a cost structure that likely relies heavily on non-operating income, such as interest earned on cash holdings, rather than operational efficiency or product sales. The company reports a free cash flow of $-168,465, which indicates a cash outflow that constrains immediate financial flexibility and suggests the entity is consuming cash reserves rather than generating liquidity from its operations. Despite this outflow, the company holds a cash balance of $145,453, which is insufficient to cover its total debt obligation of $444,938, highlighting a potential liquidity constraint. The balance sheet is leveraged, as evidenced by the debt-to-equity ratio being listed as N/A and the company carrying more debt than its cash on hand. Furthermore, the current ratio stands at 0.45, a figure below 1.0 that indicates the company possesses significantly fewer liquid assets than current liabilities, signaling potential short-term liquidity challenges. Return on equity is listed as N/A, while return on assets is recorded at -0.1%, a negative metric that reveals management is not generating positive returns on the assets currently deployed, likely due to the high debt load relative to the small cash reserve.
Valuation Assessment
The valuation metrics for GP-Act III Acquisition Corp. include a trailing P/E ratio and a forward P/E that are both listed as N/A, implying that traditional earnings-based valuation multiples are not applicable or available for analysis at this time. The price-to-book ratio is stated at -0.44, a negative figure that indicates the market capitalization is less than the company's book value or suggests an accounting structure where equity is negative, reflecting the debt burden relative to assets. The price-to-sales ratio and EV/EBITDA are both listed as N/A, meaning alternative valuation metrics that rely on sales or earnings before interest, taxes, depreciation, and amortization cannot be calculated with the provided data. The stock's price volatility is contextualized by a 52-week high of $0.18 and a 52-week low of $0.17, placing the current trading range within a very narrow band of just one cent. The beta value is listed as N/A, preventing a direct comparison of price volatility relative to the broader market index. Given the 52-week high of $0.18 and low of $0.17, the stock is trading in a highly compressed range where the difference between the high and low represents less than a 6% fluctuation, suggesting low price movement relative to the broader market despite the lack of a calculated beta.
Growth & Income
The growth profile of GP-Act III Acquisition Corp. shows a revenue growth year-over-year listed as N/A and an earnings growth year-over-year of -15.1%, indicating a contraction in earnings despite the absence of reported revenue figures. Since the revenue growth is unavailable and earnings are declining, it is not possible to determine if earnings are growing faster or slower than revenue, but the negative earnings growth suggests a deteriorating financial position regarding profitability. The company does not pay dividends, as the dividend yield and payout ratio are both listed as N/A, meaning the entity reinvests any available earnings or retains cash to fund its search for a business combination rather than distributing income to shareholders. The overall growth and income profile is defined by a lack of traditional growth metrics and a negative earnings trajectory, which is consistent with a SPAC vehicle that has not yet identified a target to commence commercial operations and generate sustainable income streams.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About GP-Act III Acquisition Corp.
GP-Act III Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. GP-Act III Acquisition Corp. was incorporated in 2020 and is based in New York, New York.
Visit website →Key Statistics
- Market Cap
- N/A
- P/E Ratio
- N/A
- 52-Week High
- $0.16
- 52-Week Low
- $0.16
Data provided by Yahoo Finance via yfinance. Updated daily.
Company Info
- Exchange
- NASDAQ
- Country
- United States